Name Tissue Type of pathologies
Acute and chronic muscle aches and pain Muscle Pain management
Acute and chronic cervical and lumbar pain Muscle Idiopathic cervical and low back pain
Acute and chronic soft tissue wounds Skin Wounds
Adhesive capsulitis Joint Capsulitis
Calcifying tendinitis of the shoulder Tendons Tendinopathy
Cellulite Skin Cellulite
Chronic distal biceps tendinopathy Tendons Tendinopathy
Chronic proximal hamstring tendinopathy Tendons Tendinopathy
Diseases secondary to trigger points and myofascial Pain Muscle Myofascial pain syndrome
Golfer’s elbow Tendons Tendinopathy
Greater trochanteric pain syndrome Tendons Tendinopathy
Insertional Achilles tendinopathy Tendons Tendinopathy
Knee osteoarthritis Joint Osteoarthritis
Medial tibial stress syndrome Tendons Tendinopathy
Mid-body Achilles tendinopathy Tendons Tendinopathy
Osgood-Schlatter disease Bone Disturbance of musculoskeletal development
Patella tip syndrome Tendons Tendinopathy
Plantar fasciopathy Tendons Tendinopathy
Primary and secondary lymphedema Skin Lymphedema
Primary long bicipital tenosynovitis Tendons Tendinitis
Proliferative connective tissue disorders Connective tissue Fibrosis
Spasticity Central nervous system Cerebral palsy and stroke
Stress fractures Bone Fracture
Subacromial pain syndrome Tendons Tendinopathy
Superficial nonunions Bone Fracture
Tennis elbow Tendons Tendinopathy
Trigger points Muscle Myofascial pain syndrome


Cellulite is defined as a localized metabolic disorder of subcutaneous tissue.

The main clinical symptom is a modification of the topography of the skin characterized by skin dimpling and nodularity. Diagnosis is based on the clinical features of the disease. At the microscopic level, cellulite presents with herniation of subcutaneous fat with fibrous connective tissue, leading to an orange peel-like or padded appearance of the skin.

The condition occurs mainly in postpubertal women on the pelvic region, lower limbs and the abdomen, and is divided in four stages.
The first stage affects the microcirculation of the skin, with no superficial changes observed.
During the second stage (secretion stage) the vasodilation is converted into the release of liquids to the extracellular space, and the skin starts to develop an orange peel-like texture.
The third stage (fibrosing stage) is characterized by an increase in number and size of adipose cells which form micronodules (cluster). The hypodermal septa thicken and become turgid. The spongy appearance of the skin becomes obvious in a lying position.
The fourth stage (sclerosis stage) can be seen as aggravation of the fibrosing stage, with the hypodermal septa becoming harder and further thickening. The irregularities, depressions and protrusions of the skin are visible to the naked eye.

The etiology of cellulite is multifactorial, with the following factors playing important roles:
(i) genetic predisposition;
(ii) gender (females >>males);
(iii) ethnicity (caucasians >> Asian women);
(iv) lifestyle (an excessive, high-carbohydrate diet results in hyperinsulinemia, promoting lipogenesis; and prolonged periods of sitting and/or standing may cause alterations in the microcirculation of cellulite prone areas); and
(v) pregnancy.

Additional factors are localized tissue vascularity, hormonal influences, and postinflammatory changes. However, the actual differences between the pathophysiology of cellulite and ‘‘normal’’ fat are largely unknown.

Approximately 85-98% of all postpubertal females display some degree of cellulite, without definite explanation for its presentation. Nevertheless, affected women seem to have fewer and mostly perpendicular hypodermal fibrous septae, whereas these septae are more and arranged in a “criss-cross” pattern in unaffected men and women.

Various treatments for cellulite have been developed, such as (in order of decreasing evidence-based medicine [EbM] level*): laser-assisted lipolysis (EbM level I-A), topical phosphatidylcholine and LED (I-A), endermology (II-A), radiofrequency (II-A), topical herbs and retinol (II-A), ultrasound (II-A), carboxy therapy (II-B), mesotherapy (II-B), weight loss (II-B), liposuction (III), cryolipolysis (IV), and subcision (IV). Radial shock wave therapy (RSWT) has been demonstrated being efficient for cellulite stages II and III (EbM level IIB), with improvement by approximately one stage for several months.


*Level IA: evidence from metaanalysis of randomized controlled trials.
Level IB: evidence from at least one randomized controlled trial.
Level IIA: evidence from at least one controlled study without randomization.
Level IIB: evidence from at least one other type of experimental study.
Level III: evidence from nonexperimental descriptive studies, such as comparative studies, correlation studies, and case control studies
Level IV: evidence from expert committee reports or opinions or clinical experience of respected authorities, or both.



Schlaudraff et al., Clin Cosmet Investig Dermatol 2014;7:171-183.

Predictability of the individual clinical outcome of extracorporeal shock wave therapy for cellulite



Number of treatment sessions 8
Interval between two sessions 2 times a week
Air pressure Evo Blue® 3 to 4 bar
Air pressure Power+ 2.5 to 4 bar
Impulses 200 - 300 impulses / cm2
Frequency 12Hz to 20Hz
Applicator 36mm
Skin pressure Heavy

I agree that E.M.S. Electro Medical Systems S.A., with registered office at Che. de la Vuarpillière 31, CH 1260-Nyon, collects the personal information that I have filled in above. These information will be used to provide me with the services requested above.

I would like to receive quarterly newsletters of E.M.S. Electro Medical Systems S.A. by email with updates about its medical products, and the SDCA. I understand that my data will be used in order to receive marketing information and will not be forwarded to third parties.
I can revoke my consent at any time by sending an email to with effect for the future, or by clicking on the unsubscribe link on each email.

SHOCK WAVE Survey Haven't submitted your opinion yet?
we have a new Price. Click below to
Click & Win